Bulletin of Environmental Contamination and Toxicology 2009-11-01

Episodic trihalomethane species and levels in tap water at a start of operation of advanced treatment in Osaka Prefectural water supplies.

Kohji Yamamoto, Yoshiaki Mori

Index: Bull. Environ. Contam. Toxicol. 83(5) , 674-6, (2009)

Full Text: HTML

Abstract

Dramatic changes in trihalomethanes of tap water caused by decreasing the chlorine dose from to break-point to zero at a pre-chlorination could be found during several years from starting the advanced treatment in Osaka Prefectural water utilities (from 1998 to 2002). In 1998 (break-point chlorination), chloroform was predominant (an average of 14.3 microg/L) and bromodichloromethane (5.96 microg/L), dibromochloromethane (4.19 microg/L) and bromoform (1.06 microg/L) were in the decreasing order. In contrast, in 1999 (chloramination), dibromochloromethane and bromodichloromethane were abundant trihalomethanes (6.61 and 5.72 microg/L) and followed by chloroform (4.14 microg/L) and bromoform (1.41 microg/L). Trihalomethane distribution in 2002 (non-chlorination) was almost the same as that in 1999.

Related Compounds

  • BROMODICHLOR...
  • Bromoform
  • Dibromomethane

Related Articles:

Use of urinary trichloroacetic acid as an exposure biomarker of disinfection by-products in cancer studies.

2014-11-01

[Environ. Res. 135 , 276-84, (2014)]

Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.

2009-09-01

[Eur. J. Med. Chem. 44 , 3658-64, (2009)]

Comparing a silver-impregnated activated carbon with an unmodified activated carbon for disinfection by-product minimisation and precursor removal.

2016-01-15

[Sci. Total Environ. 542 , 672-84, (2015)]

Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.

2007-11-01

[J. Expo. Sci. Environ. Epidemiol. 17(7) , 591-603, (2007)]

CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

2014-01-01

[Toxicol. Appl. Pharmacol. 274(1) , 42-54, (2014)]

More Articles...